Altered pharmacokinetics of 1α,25-dihydroxyvitamin D3 and 25-hydroxyvitamin D3 in the blood and tissues of the 25-hydroxyvitamin D-24-hydroxylase (Cyp24a1) null mouse

被引:119
作者
Masuda, S
Byford, V
Arabian, A
Sakai, Y
Demay, MB
St-Arnaud, R
Jones, G [1 ]
机构
[1] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada
[2] Shriners Hosp Children, Genet Unit, Montreal, PQ H3G 1A6, Canada
[3] McGill Univ, Dept Med, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Dept Surg, Montreal, PQ H3A 2T5, Canada
[5] McGill Univ, Dept Human Genet, Montreal, PQ H3A 2T5, Canada
[6] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Endocrine Unit, Boston, MA 02114 USA
关键词
D O I
10.1210/en.2004-1116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The 25-hydroxyvitamin D-24-hydroxylase (CYP24A1) plays an important role in regulating concentrations of both the precursor 25-hydroxyvitamin D-3 [25(OH)D-3] and the hormone 1alpha,25-dihydroxyvitamin D-3 [1alpha,25(OH)(2)D-3]. Previous studies suggest that Cyp24a1-null mice cannot clear exogenous 1alpha,25(OH)(2)D-3 efficiently. Here, we examined the metabolic clearance in Cyp24a1-null mice in vivo and in vitro using a physiological dose of [1beta-H-3]1alpha,25(OH)(2)D-3 or [26,27-methyl-H-3] 25(OH)D-3. Cyp24a1-null mice showed difficulty in eliminating [1beta-H-3]1alpha,25(OH)(2)D-3 from the bloodstream and tissues over a 96-h time course, whereas heterozygotic mice eliminated the hormone within 6-12 h, although there was clearance of labeled hormone into water-soluble products involving liver in both genotypes. RT-PCR showed that Cyp24a1-null mice have decreased expression of 25-hydroxyvitamin D-1alpha-hydroxylase that must play a role in their survival. After the administration of [26,27-methyl-H-3]25(OH)D-3, Cyp24a1-null mice showed higher [26,27-methyl-H-3]25(OH)D-3 levels and no [26,27-methyl-H-3]24,25(OH)(2)D-3 formation, whereas heterozygotic mice showed significant [26,27-methyl-H-3]24,25(OH)(2)D-3 production. Based upon in vitro experiments, keratinocytes from Cyp24a1-null mice fail to synthesize [1beta-H-3] calcitroic acid from [1beta-H-3] 1alpha,25(OH)(2)D-3 or [26,27-methyl-H-3]24,25(OH)(2)D-3 from [26,27-methyl-H-3]25(OH)D-3 as do control mice, confirming the target cell catabolic role of CYP24A1 in these processes. Finally, the role of vitamin D receptor (VDR) in the vitamin D catabolic cascade was examined using VDR-null mice. Keratinocytes from VDR-null mice failed to metabolize [1beta-H-3]1alpha,25(OH)(2)D-3 confirming the importance of vitamin D-inducible, VDR-mediated, C24 oxidation pathway in target cells. These results suggest that the absence of CYP24A1 or VDR retards catabolism of 1alpha,25(OH)(2)D-3 and 25(OH)D-3, reinforcing the physiological importance of CYP24A1 in vitamin D homeostasis.
引用
收藏
页码:825 / 834
页数:10
相关论文
共 39 条
  • [21] LONDOWSKI JM, 1986, J PHARMACOL EXP THER, V237, P837
  • [22] TARGET-CELL METABOLISM OF 1,25-DIHYDROXYVITAMIN-D3 TO CALCITROIC ACID - EVIDENCE FOR A PATHWAY IN KIDNEY AND BONE INVOLVING 24-OXIDATION
    MAKIN, G
    LOHNES, D
    BYFORD, V
    RAY, R
    JONES, G
    [J]. BIOCHEMICAL JOURNAL, 1989, 262 (01) : 173 - 180
  • [23] Masuda S, 2003, RECENT RESULTS CANC, V164, P189
  • [24] Masuda Sonoko, 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P43, DOI 10.2174/1568008033340315
  • [25] OHYAMA Y, 1994, J BIOL CHEM, V269, P10545
  • [26] OHYAMA Y, 1991, J BIOL CHEM, V266, P8690
  • [27] Hydroxylase enzymes of the vitamin D pathway: Expression, function, and regulation
    Omdahl, JL
    Morris, HA
    May, BK
    [J]. ANNUAL REVIEW OF NUTRITION, 2002, 22 : 139 - 166
  • [28] METABOLISM OF H-3 1-ALPHA,25-DIHYDROXYVITAMIN D-3 IN CULTURED HUMAN KERATINOCYTES
    RAY, S
    RAY, R
    HOLICK, MF
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 59 (01) : 117 - 122
  • [29] Evaluation of keratinocyte proliferation and differentiation in vitamin D receptor knockout mice
    Sakai, Y
    Demay, MB
    [J]. ENDOCRINOLOGY, 2000, 141 (06) : 2043 - 2049
  • [30] Dual metabolic pathway of 25-hydroxyvitamin D3 catalyzed by human CYP24
    Sakaki, T
    Sawada, N
    Komai, K
    Shiozawa, S
    Yamada, S
    Yamamoto, K
    Ohyama, Y
    Inouye, K
    [J]. EUROPEAN JOURNAL OF BIOCHEMISTRY, 2000, 267 (20): : 6158 - 6165